Rockwell Medical, Inc., together with its subsidiaries, develops, manufactures, commercializes, and distributes various hemodialysis products for dialysis providers worldwide. The company offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, centrisol and renasol hemodialysis concentrates, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers. Its hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. In addition, the company offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process. The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan. Show more

30142 South Wixom road, Wixom, MI, 48393, United States

Drug Manufacturers - Specialty & Generic
Healthcare

Market Cap

35.31M

52 Wk Range

$0.78 - $2.10

Previous Close

$0.90

Open

$0.89

Volume

440,826

Day Range

$0.89 - $0.97

Enterprise Value

24.73M

Cash

23.71M

Avg Qtr Burn

-1.307M

Insider Ownership

12.40%

Institutional Own.

8.92%

Qtr Updated

09/30/25